Particularităţi în terapia biologică cu Infliximab la pacienţii cu rectocolită ulcerohemoragică

Particularităţi în terapia biologică cu Infliximab la pacienţii cu rectocolită ulcerohemoragică

Rectocolita ulcerohemoragică (RCUH) este o afecțiune digestivă cronică, caracterizată de inflamarea pereților colonului, cu afectarea inițială a rectului și implicarea în mod continuu a întregului intestin gros, cu multiple complicații. RCUH va rămâne mereu actuală, prin creșterea constantă a incide...

Full description

Bibliographic Details
Main Authors:	Svetlana Chişlaru, Ion Ţîbîrnă, Rodica Bugai, Doina Munteanu, Elena Platon, Elena Josan
Format:	Article
Language:	English
Published:	Academy of Sciences of Moldova 2019-05-01
Series:	Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale
Subjects:	rectocolită ulcerohemoragică infliximab polipoza intestinală
Online Access:	https://bulmed.md/bulmed/article/view/3042

Similar Items

BOLILE INFLAMATORII INTESTINALE IDIOPATICE LA COPII – EVALUARE ENDOSCOPICÅ
by: Alice Bălăceanu, et al.
Published: (2010-06-01)

OCLUZIA INTESTINALĂ ACUTĂ LA GRAVIDE
by: Irina PALADII, et al.
Published: (2024-01-01)

Alergoze acute factori cauzali și aspecte clinicoparaclinice
by: Maria Feghiu, et al.
Published: (2019-05-01)

Rupturile şi perforațiile diastatice de cec consecutive ocluziei intestinale acute tumorale.
by: Sergiu Revencu, et al.
Published: (2019-05-01)

MANIFESTĂRI ARTICULARE ÎN BOLILE INFLAMATORII INTESTINALE LA COPIL
by: Ancuţa Ignat, et al.
Published: (2013-09-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

Uso de infliximabe na policondrite recidivante Infliximab in relapsing polychondritis
by: Ana Paula Soares de Barros, et al.
Published: (2010-04-01)

Comparative analysis of GSTM1/GSTT1 null alleles and Ile105Val GSTP1 variant in patients with Nasal Polyposis and hyposmia in a Romanian population group
by: Cătană Iuliu Vlad, et al.
Published: (2013-06-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

IMPACTUL MICROBIOTEI INTESTINALE ASUPRA EVOLUȚIEI SPONDILITEI ANCHILOZANTE
by: Lia Chislari
Published: (2023-12-01)

Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis Infliximab induce respuesta clínica, endoscópica e histológica en la colitis ulcerosa refractaria
by: F. Bermejo, et al.
Published: (2004-02-01)

COLITA ULCERATIVĂ ŞI BOALA CROHN LA VÂRSTĂ PEDIATRICĂ – TENDINŢE DE EVOLUŢIE ÎN ROMÂNIA
by: Cristina Becheanu, et al.
Published: (2014-06-01)

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)

Particularităţile tratamentului pneumoniilor comunitare la pacienţii cu COVID-19
by: Carolina Catcov, et al.
Published: (2021-05-01)

Observații terapeutice a gastropatiei portal hipertensive la pacienţii cu ciroză hepatică virală C.
by: Svetlana Chişlaru
Published: (2019-05-01)

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab Pioderma gangrenoso asociado a colitis ulcerosa: respuesta a infliximab
by: A. López San Román, et al.
Published: (2004-06-01)

GOUT – induced by Infliximab?- case report
by: Anca Chiriac, et al.
Published: (2012-10-01)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021-02-01)

Early infliximab antibody testing does not prevent infusion reactions when reinitiating infliximab
by: Joseph D. Feuerstein
Published: (2016-08-01)

PREVENȚIA CANCERULUI GASTRIC ÎN BOLILE PROFESIONALE
by: Adriana Botezatu, et al.
Published: (2022-11-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia
by: Marika Cordaro, et al.
Published: (2022-05-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
by: Peyman Adibi, et al.
Published: (2011-01-01)

Serum infliximab levels and clinical response in hidradenitis suppurativa
by: Erwin Benassaia, et al.
Published: (2023-06-01)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
by: Mitsuro Chiba, et al.
Published: (2019-08-01)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
by: Salehzadeh F, et al.
Published: (2019-05-01)

Uso do infliximabe e aparecimento sequencial de autoanticorpos e neoplasia em paciente com espondiloartrite Infliximab use and sequential occurrence of autoantibodies and neoplasia in a patient with spondyloarthritis
by: Ricardo Golmia, et al.
Published: (2010-12-01)

Difficult diagnosis of Infliximab-related miliary tuberculosis
by: S. Contini, et al.
Published: (2004-06-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006-01-01)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
by: van der Maas Aatke, et al.
Published: (2012-09-01)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
by: Seong Yeon Jeong, et al.
Published: (2014-01-01)

Dramatic response to infliximab in refractory neurosarcoidosis
by: Chintamaneni Sreekanth, et al.
Published: (2010-01-01)

Adenocarcinoma de recto y ano en paciente con enfermedad de Crohn tratado con infliximab Adenocarcinoma of the rectum and anus in a patient with Crohn´s disease treated with infliximab
by: J. Egea Valenzuela, et al.
Published: (2010-08-01)

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
by: Lianna Valdes, et al.
Published: (2022-09-01)

Dislipidemiile în asociere cu alți factori de risc în pancreatita cronică
by: Rodica Bugai, et al.
Published: (2019-05-01)